| Subhash Ramanlal Patel, MD | |
|
300 W Wallace St, Suite A5, Findlay, OH 45840-1242 | |
| (419) 425-1600 | |
| (419) 425-0600 |
| Full Name | Subhash Ramanlal Patel |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 300 W Wallace St, Findlay, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023186269 | NPI | - | NPPES |
| 0968181 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 66378 (Ohio) | Primary |
| Entity Name | Specialty Physicians Of Blanchard Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689835415 PECOS PAC ID: 2668547613 Enrollment ID: O20080826000542 |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
A multi-institutional study has defined and established criteria for a new neurological disease closely resembling Alzheimer's disease called primary age-related tauopathy (PART).
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.
The American Clean Skies Foundation (ACSF) released a new report today on the plans of the Environmental Protection Agency (EPA) to adopt stricter pollution controls for electric power plants. The report concludes that the EPA's proposed actions are likely to spur major changes in the fuels used by the utility sector - with greater reliance on cleaner sources such as natural gas and renewable energy - and should not present reliability concerns.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Subhash Ramanlal Patel, MD 300 W Wallace St, Suite A5, Findlay, OH 45840-1242 Ph: (419) 425-1600 | Subhash Ramanlal Patel, MD 300 W Wallace St, Suite A5, Findlay, OH 45840-1242 Ph: (419) 425-1600 |
News Archive
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
A multi-institutional study has defined and established criteria for a new neurological disease closely resembling Alzheimer's disease called primary age-related tauopathy (PART).
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.
The American Clean Skies Foundation (ACSF) released a new report today on the plans of the Environmental Protection Agency (EPA) to adopt stricter pollution controls for electric power plants. The report concludes that the EPA's proposed actions are likely to spur major changes in the fuels used by the utility sector - with greater reliance on cleaner sources such as natural gas and renewable energy - and should not present reliability concerns.
› Verified 5 days ago